Pfizer Ltd.

NSE: PFIZER | BSE: 500680 | ISIN: INE182A01018 | Industry: Pharmaceuticals
| Expensive Performer
5706.5000 -90.50 (-1.56%)
NSE Jun 06, 2025 15:31 PM
Volume: 23,374
 

logo
Pfizer Ltd.
20 Apr 2020
5706.50
-1.56%
ICICI Securities Limited
On the business front, despite the nationwide lockdown, domestic growth is expected to remain more or less stable. Exports growth, barring for one or two months due to congestion in all major ports globally, is also expected to remain strong due to 1) currency benefit, 2) slowdown in competition due to delay in new approvals that will be beneficial for existing players and 3) expected demand continuum across the world despite Covid-19. Some windfall is also expected in some critical productsa case in point is Hydroxychloroquine, a malaria drug that is likely to be repurposed as a prophylaxis for Covid-19 treatment in some cases....
Pfizer Ltd. is trading above all available SMAs
More from Pfizer Ltd.
Recommended